The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Larson Yi since 2019.
This trader's CIK number is 1785987.
At the time of last reporting, Larson Yi was the EVP & Chief Financial Officer of Turning Point Therapeutics, Inc.. (stock ticker symbol TPTX).
Also see all insider trading activities at Turning Point Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | TPTX | 0 | $0 | 30,000 | $3,805,504 | 30,000 | $1,620,899 |
| 2019 | TPTX | 2,222 | $99,990 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-02 | TPTX | Sale | 14,298 | 129.62 | 1,853,306 |
| 2021-02-01 | TPTX | Sale | 15,702 | 124.33 | 1,952,198 |
| 2021-02-02 | TPTX | Option Ex | 14,298 | 54.03 | 772,520 |
| 2021-02-01 | TPTX | Option Ex | 15,702 | 54.03 | 848,379 |
| 2019-09-10 | TPTX | Buy | 2,222 | 45.00 | 99,990 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Larson Yi (EVP & Chief Financial Officer of Turning Point Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.